2021 annual financial data
Cue Biopharma 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -259.93%.
Operating income was -43,712,073 USD and net income was -44,161,175 USD.
Operating cash flow was -38,837,166 USD.
Get free Cue Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 14,941,370 USD
- Operating income
- -43,712,073 USD
- Net income
- -44,161,175 USD
- Operating cash flow
- -38,837,166 USD